The colocalization of several TNF receptor superfamily members (TNFRSF1A, TNFRSF9, and TNFRSF14) further supports the development of drugs modulating TNF pathway, one of the main therapy lines for treating immune diseases. This evidence concerns the gene TNF and immune system disorder.